Stock listing

NASDAQ:DNDN Dendreon Corp Stock

Follow Dendreon Corp into a list and get an email when it puts out news.

Delisted NASDAQ:DNDN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:DNDN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Dendreon Corp on 6ix

Decks
4 decks · latest May 1, 2009

Decks

DeckKindSlidesDate
Technical Presentation (May 2009)Technical17 slidesMay 1, 2009
Merger or Acquisition (July 2003)Merger or acquisition39 slidesJul 7, 2003
Merger or Acquisition (June 2003)Merger or acquisition14 slidesJun 10, 2003
Merger or Acquisition (April 2003)Merger or acquisition42 slidesApr 15, 2003

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David C Stump
Other companies: Regenxbio Inc. (Director · Since at least Oct 14, 2015); MacroGenics, Inc. (Director · Since at least Oct 9, 2013); Portola Pharmaceuticals Inc (Director · Sep 24, 2015 – Jul 2, 2020 · Past); Sunesis Pharmaceuticals Inc (Director · Jun 18, 2009 – Jun 30, 2020 · Past); Human Genome Sciences Inc (Exec. Vice President · Mar 10, 2009 – Jul 30, 2012 · Past)
Director · Jun 2, 2010 – Jan 3, 2014 · Past
Mark W. Frohlich
Other companies: Rigel Pharmaceuticals, Inc. (Director · Since at least Mar 6, 2025); Juno Therapeutics Inc (See Remarks · Dec 18, 2014 – Feb 29, 2016 · Past)
EVP, R&D and CMO · Apr 3, 2013 – Jan 20, 2014 · Past
David UrdalDirector · Apr 30, 2010 – Jan 3, 2014 · Past

Open People

Log in to ask 6ix AI your own questions about Dendreon Corp.